(2-(2,3,4-TRIFLUOROPHENYLIMINO)OXAZOLIDINE-4,4-DIYL)DIMETHANOL


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	GIWMOQTVFFAUOW-UHFFFAOYSA-N
Smiles	OCC1(CO)CO\C(=N/c2ccc(F)c(F)c2F)\N1
InChI	InChI=1S/C11H11F3N2O3/c12-6-1-2-7(9(14)8(6)13)15-10-16-11(3-17,4-18)5-19-10/h1-2,17-18H,3-5H2,(H,15,16)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C11H11F3N2O3
Molecular Weight	276.21
AlogP	1.1
Hydrogen Bond Acceptor	5.0
Hydrogen Bond Donor	3.0
Number of Rotational Bond	3.0
Polar Surface Area	74.08
Molecular species	NEUTRAL
Aromatic Rings	1.0
Heavy Atoms	19.0

Assay Description	Organism	Bioactivity
Insecticidal activity against adult Drosophila melanogaster cultured on compound-treated corn media assessed as inhibition of flight at 200 ppm after 48 hr relative to control	Drosophila melanogaster	16.6 %
Inhibition of Sus scrofa (pig) trehalase using trehaloase as substrate incubated for 15 min prior to substrate addition measured after 1.5 hr by spectrophotometric analysis	Sus scrofa	85113.8 nM
Larvicidal activity against Drosophila melanogaster at 200 ppm relative to control	Drosophila melanogaster	50.4 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2270890
PubChem	10880360

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).